Skyrizi 150 mg/mL single-dose prefilled pen Images
Generic Name: risankizumab
This medication has been identified as Skyrizi 150 mg/mL single-dose prefilled pen. It is supplied by AbbVie Inc.
Skyrizi is used in the treatment of Crohn's Disease; Ulcerative Colitis; Psoriatic Arthritis; Psoriasis; Plaque Psoriasis and belongs to the drug class interleukin inhibitors. Skyrizi 150 mg/mL single-dose prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Skyrizi
- Generic Name
- risankizumab
- Strength
- 150 mg/mL single-dose prefilled pen
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-2100
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Vtama
Vtama (tapinarof) is a steroid-free, once-daily cream used to treat plaque psoriasis and atopic ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Medrol
Medrol is used for allergic rhinitis, asthma, asthma, acute, asthma, maintenance, congenital ...
More about Skyrizi (risankizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (59)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.